Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 01/30/2026 | CALL | $1,180.00 | 805 | +650 | +419.35% |
| 01/23/2026 | CALL | $1,100.00 | 2,108 | +513 | +32.16% |
| 01/30/2026 | PUT | $1,015.00 | 956 | +465 | +94.70% |
| 01/23/2026 | CALL | $1,110.00 | 1,259 | +405 | +47.42% |
| 01/23/2026 | CALL | $1,090.00 | 809 | +341 | +72.86% |
| 02/20/2026 | PUT | $920.00 | 781 | +339 | +76.70% |
| 01/23/2026 | CALL | $1,070.00 | 576 | -61 | -9.58% |
| 01/23/2026 | PUT | $865.00 | 287 | -63 | -18.00% |
| 01/23/2026 | PUT | $1,005.00 | 225 | -66 | -22.68% |
| 03/20/2026 | CALL | $1,200.00 | 2,418 | -89 | -3.55% |
| 01/30/2026 | PUT | $960.00 | 146 | -97 | -39.92% |
| 01/23/2026 | PUT | $1,090.00 | 204 | -227 | -52.67% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.74% | 26M | 11.45B |
| Vanguard 500 Index Fund | 1.92% | 18.23M | 8.03B |
| Vanguard/Primecap Fund | 1.56% | 14.85M | 6.54B |
| Fidelity 500 Index Fund | 0.91% | 8.65M | 3.81B |
| SPDR S&P 500 ETF Trust | 0.90% | 8.54M | 3.76B |
| Vanguard Specialized-Health Care Fund | 0.80% | 7.64M | 3.37B |
| iShares Core S&P 500 ETF | 0.74% | 7.04M | 3.1B |
| Washington Mutual Investors Fund | 0.73% | 6.95M | 3.06B |
| Growth Fund Of America Inc | 0.71% | 6.7M | 2.95B |
| Select Sector SPDR Fund-Health Care | 0.67% | 6.41M | 2.82B |
3 Growth Stocks to Invest $1,000 in Right Now
01/24 09:15 pm
The Motley Fool
Read moreWeight Loss Drugs Market Is Crowded But Structure Therapeutics CEO Has A Strategy For It
01/23 10:18 am
Benzinga
Read moreEli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026
01/23 06:10 am
The Motley Fool
Read morePostpartum Depression Drugs Market Size to Surpass USD 1.97 Billion by 2033, Due to Increasing Awareness & Fast Development of Pharmaceuticals – SNS Insider
01/22 12:00 pm
GlobeNewswire Inc.
Read moreWhat Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026?
01/20 04:05 pm
The Motley Fool
Read more3 Biotech Stocks to Keep an Eye on in 2026
01/20 09:41 am
Investing.com
Read moreDown 55%, Should You Buy the Dip on Pfizer?
01/19 04:24 pm
The Motley Fool
Read morePrediction: 2026 Will Be the Year of Eli Lilly
01/19 05:10 am
The Motley Fool
Read moreContinuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica
01/16 01:38 pm
GlobeNewswire Inc.
Read moreFDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks (UPDATED)
01/16 09:32 am
Benzinga
Read moreInSilico Lands Drug Discovery Deal After Hong Kong IPO
01/15 07:44 am
Benzinga
Read moreDigbi Health Publishes Peer-Reviewed Data Demonstrating Significant Cost Savings for Employers Via Its Precision Biology Telehealth Platform to Manage GLP-1, Metabolic, and GI Costs
01/15 04:26 am
GlobeNewswire Inc.
Read moreEli Lilly's Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain Relief
01/14 03:15 pm
The Motley Fool
Read moreWhy Eli Lilly Stock Gained 39.2% In 2025
01/14 02:13 pm
The Motley Fool
Read moreA Fresh IPO That Long-Term Investors Shouldn’t Ignore
01/14 12:20 pm
Investing.com
Read morePrediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
01/14 12:15 pm
The Motley Fool
Read moreEli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns
01/14 02:23 am
Investing.com
Read moreFDA Says No Clear Link Found Between Popular Weight Loss Drugs And Suicidal Thoughts, Review Ongoing
01/13 02:20 pm
Benzinga
Read moreEli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026?
01/13 11:15 am
The Motley Fool
Read moreWhy Tempus AI Stock Rose Today
01/12 08:07 pm
The Motley Fool
Read moreNvidia Trades Cheap Relative to Its 2030s Earnings Path
01/12 03:38 pm
Investing.com
Read moreNVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI
01/12 11:00 am
GlobeNewswire Inc.
Read moreNVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery
01/12 11:00 am
GlobeNewswire Inc.
Read moreBest GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand
01/10 07:12 pm
GlobeNewswire Inc.
Read moreFoghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
01/09 11:20 pm
GlobeNewswire Inc.
Read moreEli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight
01/09 09:45 am
Benzinga
Read moreAlveus Therapeutics annoncerer serie A-financiering på 160 mio. USD til næste generations behandlinger mod fedme og stofskiftesygdomme
01/09 04:13 am
GlobeNewswire Inc.
Read moreAktis Oncology Announces Pricing of its Upsized Initial Public Offering
01/08 09:48 pm
GlobeNewswire Inc.
Read morePharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Headquartered in Florida's Fastest-Growing Healthcare Corridor
01/08 05:30 pm
Benzinga
Read moreThe Best Technology ETF to Invest $1,000 in Right Now
01/08 11:22 am
The Motley Fool
Read moreStock Market Today: Dow Futures Up, S&P 500 And Nasdaq Slip As ADP Jobs Data Signals Modest Rebound— Mobileye, Penguin Solutions In Focus (UPDATED)
01/07 10:06 am
Benzinga
Read more2 Dividend ETFs to Buy With $500 and Hold Forever
01/07 08:30 am
The Motley Fool
Read moreMy Top 5 Stocks to Buy in Early 2026
01/07 05:15 am
The Motley Fool
Read moreArrowhead Obesity Drugs Show Significant Fat Loss In Early Human Trials
01/06 11:32 am
Benzinga
Read moreShould You Buy Eli Lilly Before It Reaches $1 Trillion in Market Value?
01/06 10:10 am
The Motley Fool
Read moreSitryx to attend J.P. Morgan Healthcare Conference 2026 showcasing pipeline of novel small molecule candidates targeting major autoimmune indications
01/06 08:00 am
GlobeNewswire Inc.
Read moreMotley Fool Money: Stock Market Naughty and Nice List
01/06 01:33 am
The Motley Fool
Read moreThese 3 Stocks Trade at Discounts the Market Won’t Ignore Forever
01/05 01:35 pm
Investing.com
Read moreHow Trump Moved Stocks In 2025: Crypto, Drones, Health Care Sectors
01/04 04:55 pm
Benzinga
Read morePfizer: Why Wall Street Gave Up—And Why That May Be a Mistake
01/02 12:24 pm
Investing.com
Read moreFDA Approves Novo Nordisk’s Wegovy Pill: A Game Changer for 2026
01/01 03:12 am
Investing.com
Read moreDrugmakers Plan Fresh Price Hikes On 350 Medicines In 2026
12/31 09:59 am
Benzinga
Read moreBest Wegovy Alternative for 2026? FDA Approves Oral Semaglutide as Patients Evaluate Compounded Telehealth Access — Direct Meds Examined as Verification Case Study
12/30 09:57 pm
GlobeNewswire Inc.
Read more